Loading...

ViaDerma, Inc.

VDRMPNK
HealthcareDrug Manufacturers - Specialty & Generic
$0.001
$0.00(0.00%)

ViaDerma, Inc. (VDRM) Stock Overview

Explore ViaDerma, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Stats data is not available for VDRMStats details for VDRM are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for VDRMAnalyst Recommendations details for VDRM are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

ViaDerma, Inc. operates as a specialty pharmaceutical company in the United States. It focuses on developing and marketing pharmaceutical products, as well as licensing its technology to companies in the pharmaceutical industry in various therapeutic areas. The company's lead product is Vitastem, a tetracycline-based topical antibiotic used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries. It is also developing products in various fields of use, including topical antibiotics, toenail antifungal drugs, diabetic amputations, global acne, psoriasis, and eczema, as well as burns, anti-aging/wrinkle remover creams, medical cannabis, male-pattern baldness, skin cancer, erectile dysfunction, and pain management. The company was formerly known as Décor Products International, Inc. and changed its name to ViaDerma, Inc. in May 2014. ViaDerma, Inc. was incorporated in 2007 and is headquartered in Marina Del Rey, California.

CEO

Dr. Christopher A Otiko

Headquarters

4640 Admiralty Way, Marina del Rey, CA

Founded

2014

Frequently Asked Questions